Gortner, L., Reiss, I. and Hilgendorff, A. (2006) Bronchopulmonary Dysplasia and Intrauterine Growth Restriction. The Lancet, 368, 28.
https://doi.org/10.1016/S0140-6736(06)68964-2

has been cited by the following article:

• TITLE: Bronchopulmonary Dysplasia in Premature Infants with Very Low Birth Weight: A Single Centre Retrospective Study in China

  AUTHORS: Li Shen, Tao Bo, Senlin Luo, Ruolin Zhang, Jian Li

  KEYWORDS: Bronchopulmonary Dysplasia, Very Low Birth Weight Infants, Oxygen Therapy, Dexamethasone, Weight Gain

  JOURNAL NAME: Open Journal of Pediatrics, Vol.6 No.4, December 5, 2016

  ABSTRACT: To investigate bronchopulmonary dysplasia (BPD) and its treatment with dexamethasone (DEX) in premature infants with birth weight (BW) P P = 0.004) and neonatal respiratory distress syndrome (OR: 6.146, P = 0.043) were independent risk factors for BPD. DEX was administered to 26 patients after the diagnosis of BPD. After one and two weeks of DEX treatment, the oxygen requirement had significantly reduced compared to the week prior to treatment (P P